SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001012168-99-000008
Filing Date
1999-01-28
Accepted
1999-01-28 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE H. BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLC /ADVFARALL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D SC 13D/A 97265
  Complete submission text file 0001012168-99-000008.txt   100053
Mailing Address ONE MARITIME PLAZA SUITE 1325 SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLZ STE 1325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC /ADV (Filed by) CIK: 0001012168 (see all company filings)

IRS No.: 943240279 | State of Incorp.: DE | Fiscal Year End: 1231

Mailing Address 1454 PAGE MILL RD PALO ALTO CA 94304
Business Address 1454 PAGE MILL RD PALO ALTO CA 94304 6504945600
CRESCENDO PHARMACEUTICALS CORP (Subject) CIK: 0001042138 (see all company filings)

IRS No.: 770460388 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51643 | Film No.: 99515086
SIC: 2834 Pharmaceutical Preparations